An update from Dr Reddy’s Laboratories ( (RDY)) is now available. On November 13, 2025, Dr. Reddy’s Laboratories announced the allotment of 7,430 equity shares to eligible employees under its ...

Looking ahead to 2030, our model projects RDY could trade at an average price of $20.74, with a potential range between $15.56 and $25.93. This represents a potential 56.8% return from today's price.

We recently published a list of the 10 Best Indian Stocks to Buy According to Billionaires. In this article, we will take a look at where Dr. Reddy’s Laboratories Limited (NYSE:RDY) stands against ...

Esperion Therapeutics ESPR announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories RDY related to patents for the marketed drugs, Nexletol (bempedoic acid) and Nexlizet ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Alvotech (NASDAQ:ALVO) on Thursday collaborated with Dr. Reddy's Laboratories Ltd. (NYSE:RDY) to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global ...